METABOLIC LIVER FUNCTION TEST TO PREDICT MORBIDITY/MORTALITY IN LIVER CIRRHOSIS
METABOLIC LIVER FUNCTION TEST TO PREDICT MORBIDITY/MORTALITY IN LIVER CIRRHOSIS
批准号:
6304982
负责人:
Mitchell L Shiffman
金额:
$0.06万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-12-01 至 2000-11-30
中文摘要
一项确定肝移植最佳时机的研究。肝移植是肝硬化和终末期肝病患者的最佳治疗方法。在过去的几年里,这种手术的成功率为80%或更高。目前有超过4500人在等待肝脏移植。等待时间的长度随着名单的增加而增加。通常每年只有3500名捐赠者,大约1000人会在等待捐赠肝脏的过程中出现严重并发症并死亡。需要一种能够更准确地确定患者并发症风险的测试,因此,可以对列表进行优先排序。大约750名被转介到该机构进行肝移植的成年人将被研究。受试者的预期平均年龄为50岁。每个月对患者进行肝硬化症状监测。患者将接受常规的肝功能检查和新的检查,以优先考虑他们的移植。分解和/或排泄某些药物的能力是一种更准确地衡量肝功能好坏的方法。两个测试是a)分解利多卡因(一种局部麻醉剂)的能力和b)分泌吲哚菁绿(一种无活性染料)的能力。几项研究表明,这些测试可以用来预测肝脏移植后的表现,以及肝病患者在一年内的表现。将按月抽取血液样本。一般临床研究中心将进行门诊检查,在那里进行代谢肝功能检查、血液检查、移植前检查和生命体征评估。将进行持续的营养评估。
英文摘要
A study to determine the best time to perform a liver transplant. Liver transplantation is the best therapy for patients with cirrhosis and end-stage liver disease. This procedure has a success rate of 80% or better over the past several years. There is an active waiting list for liver transplant of over 4500 people. The length of the waiting period increases as the list increases. There are usually only 3500 donors annually and about 1000 people will develop major complications and die while waiting for a donor liver. A test is needed that can more accurately determine the patient's risk of complications, thus, the list can be prioritized. Approximately 750 adults who are referred to this institution for liver transplants will be studied. The anticipated average age of the subjects is 50 years. Patients will be monitored at monthly intervals for symptoms of cirrhosis. The patients will receive the usual liver-function tests and new tests to prioritize them for transplant. The ability to break down and/or excrete certain medications is a way to more accurately measure how well the liver functions. Two such tests are a) the ability to break down lidocaine (a local anesthetic) and b) the ability to excrete indocyanine green (an inactive dye). Several studies have shown that these tests can be used to predict how well a liver will perform following transplantation and how well a patient with liver disease will do over a period of one year. Blood samples will be obtained on a monthly basis. There will be outpatient visits to the General Clinical Research Center where metabolic liver function tests, blood tests, pre-transplant testing, and vital sign assessment will be done. Continuous nutritional assessments will be done.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ANCILLARY STUDY TO THE HALT-C ANTI-VIRAL LONG-TERM TREATMENT AGAINST CIRRHOSI
-
批准号:8166566
-
项目类别:
-
资助金额:$0.13万
-
财政年份:2009
-
负责人:Mitchell L Shiffman
-
依托单位:
CLINICAL TRIAL: HEP C ANTIVIRAL LONG-TERM TREATMENT AGAINST CIRRHOSIS (HALT-C)
-
批准号:7950846
-
项目类别:
-
资助金额:$19.64万
-
财政年份:2008
-
负责人:Mitchell L Shiffman
-
依托单位:
ANCILLARY STUDY TO THE HALT-C ANTI-VIRAL LONG-TERM TREATMENT AGAINST CIRRHOSI
-
批准号:7950902
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2008
-
负责人:Mitchell L Shiffman
-
依托单位:
QUANTITATIVE ASSESSMENT OF HEPATIC FUNCTION IN CHRONIC HEPATITIS C
-
批准号:7717010
-
项目类别:
-
资助金额:$2.01万
-
财政年份:2007
-
负责人:Mitchell L Shiffman
-
依托单位:
CLINICAL TRIAL: HEP C ANTIVIRAL LONG-TERM TREATMENT AGAINST CIRRHOSIS (HALT-C)
-
批准号:7717009
-
项目类别:
-
资助金额:$21.35万
-
财政年份:2007
-
负责人:Mitchell L Shiffman
-
依托单位:
QUANTITATIVE ASSESSMENT OF HEPATIC FUNCTION IN CHRONIC HEPATITIS C
-
批准号:7604993
-
项目类别:
-
资助金额:$4.85万
-
财政年份:2006
-
负责人:Mitchell L Shiffman
-
依托单位:
HEP C ANTIVIRAL LONG-TERM TREATMENT AGAINST CIRRHOSIS (HALT-C) TRIAL
-
批准号:7604992
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2006
-
负责人:Mitchell L Shiffman
-
依托单位:
HEP C ANTIVIRAL LONG-TERM TREATMENT AGAINST CIRRHOSIS (HALT-C) TRIAL
-
批准号:7375118
-
项目类别:
-
资助金额:$23.81万
-
财政年份:2005
-
负责人:Mitchell L Shiffman
-
依托单位:
QUANTITATIVE ASSESSMENT OF HEPATIC FUNCTION IN CHRONIC HEPATITIS C
-
批准号:7375119
-
项目类别:
-
资助金额:$2.88万
-
财政年份:2005
-
负责人:Mitchell L Shiffman
-
依托单位:
HEP C ANTIVIRAL LONG-TERM TREATMENT AGAINST CIRRHOSIS (HALT-C) TRIAL
-
批准号:7201472
-
项目类别:
-
资助金额:$30.34万
-
财政年份:2004
-
负责人:Mitchell L Shiffman
-
依托单位:
NATURAL HISTORY OF CHRONIC HEP B & C AND THE EFFECTS OF ANTI-VIRAL THERAPY
-
批准号:7201474
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2004
-
负责人:Mitchell L Shiffman
-
依托单位:
QUANTITATIVE ASSESSMENT OF HEPATIC FUNCTION IN CHRONIC HEPATITIS C
-
批准号:7201473
-
项目类别:
-
资助金额:$8.88万
-
财政年份:2004
-
负责人:Mitchell L Shiffman
-
依托单位:
PEG Interferon plus Ribavirin for the treatment of HCV
-
批准号:7040936
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2003
-
负责人:Mitchell L Shiffman
-
依托单位:
Assessment of Hepatic Function in Chronic Hepatitis C
-
批准号:7040924
-
项目类别:
-
资助金额:$1.03万
-
财政年份:2003
-
负责人:Mitchell L Shiffman
-
依托单位:
Hep C Antiviral Long-term Treatment Against Cirrhosis
-
批准号:7040923
-
项目类别:
-
资助金额:$33.82万
-
财政年份:2003
-
负责人:Mitchell L Shiffman
-
依托单位:
Natural History of Chronic Hep B & C and the Effects of Anti-Viral Therapy
-
批准号:7040925
-
项目类别:
-
资助金额:$5.33万
-
财政年份:2003
-
负责人:Mitchell L Shiffman
-
依托单位:
HEPATITIS C CLINICAL TRIAL- CLINICAL CENTERS
-
批准号:6357883
-
项目类别:
-
资助金额:$42.36万
-
财政年份:1999
-
负责人:Mitchell L Shiffman
-
依托单位:
HEPATITIS C CLINICAL TRIAL- CLINICAL CENTERS
-
批准号:6083814
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1999
-
负责人:Mitchell L Shiffman
-
依托单位:
OPTIMUM PATIENT POPULATION AND DOSING REGIMEN FOR TREAMENT OF HEPATITIS C
-
批准号:6304978
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1999
-
负责人:Mitchell L Shiffman
-
依托单位:
TREATMENT OF CHRONIC HEPATITIS C W/ COMBINATION OF INTERFERON PLUS
-
批准号:6304944
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1999
-
负责人:Mitchell L Shiffman
-
依托单位: